about
The control of inflammation via the phosphorylation and dephosphorylation of tristetraprolin: a tale of two phosphatasesNovel roles of the multi-functional CCR4-NOT complex in post-transcriptional regulation.Regulation of the mRNA half-life in breast cancerRNase L attenuates mitogen-stimulated gene expression via transcriptional and post-transcriptional mechanisms to limit the proliferative responseSustained interleukin-1β exposure modulates multiple steps in glucocorticoid receptor signaling, promoting split-resistance to the transactivation of prominent anti-inflammatory genes by glucocorticoidsComputational Model of MicroRNA Control of HIF-VEGF Pathway: Insights into the Pathophysiology of Ischemic Vascular Disease and CancerA post-transcriptional mechanism pacing expression of neural genes with precursor cell differentiation status.mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype.Can we observe changes in mRNA "state"? Overview of methods to study mRNA interactions with regulatory proteins relevant in cancer related processes.AU-rich elements in the 3'-UTR regulate the stability of the 141 amino acid isoform of parathyroid hormone-related protein mRNAMCPIP1 Selectively Destabilizes Transcripts Associated with an Antiapoptotic Gene Expression Program in Breast Cancer Cells That Can Elicit Complete Tumor Regression.Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2.Nuclear tristetraprolin acts as a corepressor of multiple steroid nuclear receptors in breast cancer cells.Effects of Combined Tristetraprolin/Tumor Necrosis Factor Receptor Deficiency on the Splenic TranscriptomeTristetraprolin suppresses the EMT through the down-regulation of Twist1 and Snail1 in cancer cellsSignaling pathways that control mRNA turnover.miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer.Phylogenetic distribution and evolution of the linked RNA-binding and NOT1-binding domains in the tristetraprolin family of tandem CCCH zinc finger proteinsRNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting.Multiple functions of tristetraprolin/TIS11 RNA-binding proteins in the regulation of mRNA biogenesis and degradation.Dysregulation of TTP and HuR plays an important role in cancers.Post-transcriptional regulation of cytokine and growth factor signaling in cancer.Prognostic value of ZFP36 and SOCS3 expressions in human prostate cancer.Long Noncoding RNAs and RNA-Binding Proteins in Oxidative Stress, Cellular Senescence, and Age-Related Diseases.TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription.The role of RNA-binding protein tristetraprolin in cancer and immunity.Hsp70's RNA-binding and mRNA-stabilizing activities are independent of its protein chaperone functions.The ARE-binding protein Tristetraprolin (TTP) is a novel target and mediator of calcineurin tumor suppressing function in the skin.Dysregulation of tristetraprolin and human antigen R promotes gastric cancer progressions partly by upregulation of the high-mobility group box 1.
P2860
Q28076811-C6B8C1D8-C6D1-49DD-88C4-8F103B6CFF48Q33658496-DACF0165-7968-4449-AE8D-9ACE1DB49EC0Q34023658-5D0121A6-09F8-4A31-91CF-E4D3EF513E90Q34580412-E11820DC-695D-495D-B050-E9879D0A3D3FQ35573505-1E8C917A-0850-48A1-808C-B1F337B68235Q35847324-9259D0B2-4F86-4471-9938-C1B06897D7A0Q35863576-F79CC3B7-EAAD-418E-88EA-C2D017DD1E4EQ36110081-4A94CF91-11C1-4D3D-BFC3-C290DE15C893Q36431066-7C49786D-52E4-465D-8056-9EE014FEC2A5Q36485478-57FC9225-EF37-47A1-A6E4-9FCE2F0979A7Q36693265-952C24E7-13CA-446C-9AE3-745E2DED29C1Q36761505-30DFFFB1-38F4-4A4D-83AC-E71C8F9DE11EQ36799235-0C413289-F6BA-4BCE-967D-7F4C197D1F2FQ36811560-862C656C-8146-4809-9693-ACB150F903D2Q36962457-6CB1B69C-FB1E-47E9-8A96-01512764CEA6Q36988764-18851A63-E435-44DD-8E4D-D2645CD7FAEAQ37066933-08AA9102-555C-4E48-A468-C662F18FBDD4Q37686186-579D9B54-A2B8-4B9C-9D05-89D28525A26DQ37686220-BEF4340B-FECA-465E-BF7D-502D24A09449Q38042546-6DFA37A9-4372-4287-B218-AACBA216B2CCQ38958552-23B6B135-BE97-49F7-9759-2FA082B81FE7Q39036700-14F3954E-A04B-4C6F-97EE-1B327F113893Q40327112-2694445E-BB5A-4988-BE2E-A95912073DC6Q41294329-81B3A02C-40CE-42D2-B635-5C9CF022B1BBQ41499355-C868B777-B801-4E32-AC90-40816C40E325Q47417882-4279C577-1C23-4394-AC1A-4113C95F0C0DQ50906468-D814D8BC-955F-450C-8B39-DE41ADF76CD3Q55080447-49CF4284-A06E-4F45-B5D2-76EE2AB60E07Q55408888-A36F73A2-3D86-4519-993D-61199CD45C02
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tristetraprolin: roles in cancer and senescence.
@en
Tristetraprolin: roles in cancer and senescence.
@nl
type
label
Tristetraprolin: roles in cancer and senescence.
@en
Tristetraprolin: roles in cancer and senescence.
@nl
prefLabel
Tristetraprolin: roles in cancer and senescence.
@en
Tristetraprolin: roles in cancer and senescence.
@nl
P2093
P2860
P1476
Tristetraprolin: roles in cancer and senescence.
@en
P2093
Christina R Ross
Gerald M Wilson
Sarah E Brennan-Laun
P2860
P304
P356
10.1016/J.ARR.2012.02.005
P577
2012-02-24T00:00:00Z